Phase I and II study of induction chemotherapy with methotrexate, rituximab, and temozolomide, followed by whole-brain radiotherapy and postirradiation temozolomide for primary CNS lymphoma: NRG oncology RTOG 0227

Jon Glass, Minhee Won, Christopher J. Schultz, Daniel Brat, Nancy L. Bartlett, John H. Suh, Maria Werner-Wasik, Barbara Jean Fisher, Marcia K. Liepman, Mark Augspurger, Felix Bokstein, Joseph A. Bovi, Matthew C. Solhjem, Minesh P. Meh

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I and II study of induction chemotherapy with methotrexate, rituximab, and temozolomide, followed by whole-brain radiotherapy and postirradiation temozolomide for primary CNS lymphoma: NRG oncology RTOG 0227'. Together they form a unique fingerprint.

Medicine & Life Sciences